Your browser doesn't support javascript.
loading
Safety and efficacy of pracinostat in combination with gemtuzumab ozogamicin (PraGO) in patients with relapsed/refractory acute myeloid leukemia.
Abedin, Sameem M; Badar, Talha; Gauger, Katelyn; Michaelis, Laura C; Runaas, Lyndsey; Carlson, Karen-Sue; Murthy, Gs Guru; Atallah, Ehab.
Affiliation
  • Abedin SM; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States. Electronic address: sabedin@mcw.edu.
  • Badar T; Division of Hematology and Oncology, Mayo Clinic Jacksonville, Jacksonville, FL, United States.
  • Gauger K; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
  • Michaelis LC; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
  • Runaas L; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
  • Carlson KS; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
  • Murthy GG; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
  • Atallah E; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
Leuk Res ; 123: 106984, 2022 12.
Article in En | MEDLINE | ID: mdl-36401944
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzimidazoles / Leukemia, Myeloid, Acute Limits: Humans Language: En Journal: Leuk Res Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzimidazoles / Leukemia, Myeloid, Acute Limits: Humans Language: En Journal: Leuk Res Year: 2022 Document type: Article